Count Down to relaunch

Equinox increases stake in Rameda

Equinox increases stake in Rameda

ArabFinance: Tenth of Ramadan for Pharmaceuticals Industries and Diagnostic Reagents (Rameda) (RMDA) announced that its largest shareholder, Equinox, increased its existing stake in the company by 2.7% to 15.4%, according to the company’s statement filed to the Egyptian Exchange.

Rameda signed a strategic partnership to purchase a new antithrombotic drug.

The listed company’s extraordinary general assembly ratified issued capital increase by EGP 57.850 million.

Rameda is an Egypt-based pharmaceutical company that manufactures both human and veterinary pharmaceuticals. It operates three fully independent factories at its plant, including 20 production lines capable of producing a wide range of general medicinal forms, namely eye drops, solid dosage forms, syrups, blow-fill-seal, and lyophilized vials, among others.

#Related keywords


Recommended Stocks

04 Oct 2021
United Housing & Development UNIT

All rights reserved to Arab Finance 2020 ©

Back to top